<DOC>
	<DOCNO>NCT01867138</DOCNO>
	<brief_summary>The objective evaluate effectiveness empiric treatment cefazolin versus vancomycin newborn infant presumptive clinical sign hospital acquire bacterial sepsis probably cause Coagulase-negative staphylococcus . The investigator hypothesize newborn infant presumptive diagnosis nosocomial sepsis receive cefazolin empiric treatment would clinical outcome inferior treat vancomycin .</brief_summary>
	<brief_title>Neonatal Suspected Sepsis Treated With Cefazolin Vancomycin</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Cefazolin</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Amikacin</mesh_term>
	<mesh_term>Coagulase</mesh_term>
	<criteria>Newborn infant older three day life suspect bacterial sepsis accord attend physician , indication initial treatment vancomycin least one blood culture take prior receive antimicrobial treatment . previous treatment vancomycin week , infant refer hospital , upon admission , treat antibiotic .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>4 Months</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Coagulase negative staphylococcus</keyword>
	<keyword>nosocomial neonatal sepsis</keyword>
	<keyword>cefazolin</keyword>
	<keyword>vancomycin</keyword>
	<keyword>newborn</keyword>
</DOC>